Suven Life Sci Standalone December 2020 Net Sales at Rs 1.51 crore, down 45.43% Y-o-Y
January 29, 2021 / 09:59 AM IST
Reported Standalone quarterly numbers for Suven Life Sciences are:Net Sales at Rs 1.51 crore in December 2020 down 45.43% from Rs. 2.77 crore in December 2019.
Quarterly Net Loss at Rs. 8.15 crore in December 2020 down 80.99% from Rs. 4.50 crore in December 2019.
EBITDA stands negative at Rs. 8.75 crore in December 2020 down 150% from Rs. 3.50 crore in December 2019.
Suven Life Sci shares closed at 71.80 on January 28, 2021 (NSE) and has given 94.32% returns over the last 6 months and 255.45% over the last 12 months.
| Suven Life Sciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'20 | Sep'20 | Dec'19 | | Net Sales/Income from operations | 1.51 | 8.98 | 2.77 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1.51 | 8.98 | 2.77 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.80 | 4.86 | 2.42 | | Depreciation | 1.14 | 1.07 | 0.86 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | 7.30 | 7.02 | 6.39 | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.78 | 0.94 | 3.33 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -11.51 | -4.92 | -10.22 | | Other Income | 1.62 | 2.28 | 5.86 | | P/L Before Int., Excpt. Items & Tax | -9.89 | -2.64 | -4.36 | | Interest | 0.17 | 0.25 | 0.10 | | P/L Before Exceptional Items & Tax | -10.05 | -2.89 | -4.46 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -10.05 | -2.89 | -4.46 | | Tax | -1.91 | -0.99 | 0.04 | | P/L After Tax from Ordinary Activities | -8.15 | -1.90 | -4.50 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -8.15 | -1.90 | -4.50 | | Equity Share Capital | 12.73 | 12.73 | 12.73 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.64 | -0.15 | -0.35 | | Diluted EPS | -0.64 | -0.15 | -0.35 | | EPS After Extra Ordinary | | Basic EPS | -0.64 | -0.15 | -0.35 | | Diluted EPS | -0.64 | -0.15 | -0.35 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
